2024년 6월 3일
The annual European Society of Human Genetics conference (ESHG) is the major scientific and professional event in human genetics, bringing together European and international geneticists. At ESHG 2024 in Berlin, researchers, clinicians, and industry leaders, including Illumina, gathered to be inspired by the most recent advancements in the field.
The timing of the 57th annual conference couldn’t be better, as the Modellvorhaben (Model Project) is getting underway. This five-year pilot project will evaluate the clinical utility and cost-effectiveness of comprehensive genomic testing in Germany’s public health care system. If it’s successful, all patients with rare diseases and advanced cancers will benefit from whole-genome sequencing as standard of care in the future. Many of Illumina’s customers in Germany are involved in delivering this program, and Illumina is supporting them as they scale up their operations.
As a sponsor of the event, Illumina hosted a workshop, “Accelerating genomic medicine through national initiatives: Learning from different countries,” which featured speakers from the Center for Human Genetics and the Genomics Core, UZ Leuven in Leuven, Belgium; University Hospital Schleswig-Holstein in Kiel and Lübeck, Germany; and the Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne in Dijon, France.
Catch the video highlights of ESHG 2024 below, where we talk to conference speakers and Illumina customers for fresh insights into genomics.
